SELENON and metabolic dysfunction-associated steatohepatitis: The log-fold changes of the other three genes were in opposite directions between studies: SAT2 had higher expression in NASH in Suppli et al. (29) and lower expression in Horvath et al. (31); and ALOX5 and SELENON had lower expression in NASH in Suppli et al. (29) and higher expression in Horvath et al. (31) (Supplementary Table 4).